Wells Fargo
VBIO

Wells Fargo’s Valion Bio VBIO Stock Holding History

Wells Fargo’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$14 – 7455
2024
Q1 		$14 Hold
1
– – ﹤0.01% 7221
2023
Q4 		$20 Hold
1
– – ﹤0.01% 7225
2023
Q3 		$19 Buy
+1
New +$74 ﹤0.01% 7222
2023
Q2 		– Hold
0
– – – 7303
2023
Q1 		– Hold
0
– – – 7561
2022
Q4 		– Hold
0
– – – 7186
2022
Q3 		– Hold
0
– – – 7361
2022
Q2 		– Hold
0
– – – 7485
2022
Q1 		– Hold
0
– – – 7806
2021
Q4 		– Hold
0
– – – 7801

Other funds holding VBIO

CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's VBIO Position: Q2 2024 in Review

Wells Fargo sold out of Valion Bio (VBIO) in Q2 2024, closing a stake of 1 share — an estimated $14 sold.

Wells Fargo first reported a position in VBIO in Q3 2023 and held it in 3 quarters. The position peaked at $20 in Q4 2023. 10 funds tracked by Wall St. Rank hold VBIO as of Q2 2024.

  • Wells Fargo reported no remaining Valion Bio position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 1 Valion Bio share in Q2 2024, an estimated $14.
  • Wells Fargo first reported a position in Valion Bio in Q3 2023 and held it in 3 quarters.
  • Wells Fargo's Valion Bio position peaked at $20 in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Valion Bio as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.